Comparison of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Injection: Ranibizumab versus Bevacizumab

The aim of this study was to compare the incidence of systemic adverse events in patients treated with intravitreal injections of bevacizumab or ranibizumab, and to evaluate whether compared to ranibizumab administration, bevacizumab constitutes a higher risk for systemic adverse events. A retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Duck Jin, Kim, Yong Woo, Woo, Se Joon, Park, Kyu Hyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524442/
https://www.ncbi.nlm.nih.gov/pubmed/23255862
http://dx.doi.org/10.3346/jkms.2012.27.12.1580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524442/
https://www.ncbi.nlm.nih.gov/pubmed/23255862
http://dx.doi.org/10.3346/jkms.2012.27.12.1580

Ejemplares similares